Canadian Dermatology Centre - Probity - PPDS

Toronto, Ontario M3B 0A7

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Plaque Psoriasis

Studies at this site

• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed